Matt Park for Ross Osborne's questions to Nyxoah SA (NYXH) leadership • Q2 2025
Question
Matt Park, on for Ross Osborne at Cantor Fitzgerald, asked about the expected pace of new account openings via VAC approvals through 2025 and 2026, and requested a walkthrough of expected operating expenses and leverage during the commercial build-out.
Answer
CEO Olivier Talman noted that while VAC approval timelines vary, the company is targeting approvals from its initial list of hospitals within the next six months. CFO John Landry provided color on OpEx, stating that SG&A spending will increase significantly to support the commercial launch and could nearly double in 2026 compared to 2025, representing the majority of the investment increase.